EIF4EBP1 and cancer: Here we demonstrated that rapamycin was very effective at inhibiting classic mTORC1 downstream targets, including S6K and S6 phosphorylation, and showed minimal reduction in 4E- BP1 phosphorylation in these TSC mutant cancer cell lines.